Close

Sarepta Therapeutics (SRPT) Tops Q3 EPS by 7c

November 5, 2015 7:04 AM EST

Sarepta Therapeutics (NASDAQ: SRPT) reported Q3 EPS of ($1.11), $0.07 better than the analyst estimate of ($1.18).

For earnings history and earnings-related data on Sarepta Therapeutics (SRPT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings